Status:
UNKNOWN
The Effects of Rotator Interval Hydro-dissection in Primary Adhesive Capsulitis.
Lead Sponsor:
University of Malaya
Conditions:
Adhesive Capsulitis of Shoulder
Eligibility:
All Genders
35-65 years
Phase:
PHASE4
Brief Summary
Adhesive capsulitis (AC) is a significant cause of chronic shoulder pain and disability. Non-surgical option consisting of intraarticular corticosteroid (IA CS) injection with structured physiotherapy...
Eligibility Criteria
Inclusion
- patients with primary adhesive capsulitis
- aged 35 to 65 years of age
- duration of symptoms in between 3 to 18 months
- limitation in flexion, abduction, and external rotation greater than 30 degrees compared to normal
- limitation in internal rotation with hand to back shoulder test below L4
Exclusion
- diagnosis of connective tissue disease or inflammatory arthritis
- history of surgery to the affected shoulder
- history of shoulder dislocation/ fracture
- neurological weakness of the affected upper limb
- ultrasound findings of rotator cuff or LHBT tendinopathy
- plain radiographs showing significant glenohumeral joint osteoarthritis (Kallgren-Lawrence grade 3 or 4)
- other sources of chronic pain
- bilateral adhesive capsulitis
- history of pain intervention to the shoulder joint in the past 3 months
- allergic reaction to local anesthetic agent
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05977985
Start Date
August 1 2023
End Date
July 1 2025
Last Update
August 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.